| Phase 3 |
| NCT05804045 |
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) |
Tenosynovial Giant Cell Tumor |
Active, Not Recruiting |
| Phase 2 |
| NCT06111274 |
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer |
Advanced Pancreatic Cancer |
Recruiting |
| NCT06632262 |
A Phase 2 Clinical Study of ABSK061 and ABSK043 |
HER2-Gastric/Gastroesophageal Junction Cancer |
Recruiting |
| NCT06668103 |
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib |
Non-Small Cell Lung Cancer With EGFR Mutation |
Recruiting |
| NCT07327034 |
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression |
Hepatocellular Carcinoma (HCC) |
Recruiting |
| NCT07164170 |
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT06186804 |
A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the… |
cGvHD |
Enrolling by Invitation |
| NCT05441475 |
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients |
Hepatocellular Carcinoma |
Enrolling by Invitation |
| NCT07710612 |
A Phase 2 Study of ABSK043 Combined With Osimertinib |
Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive |
Not Yet Recruiting |
| Phase 1/2 |
| NCT07417189 |
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) |
Solid Tumors, Adult |
Recruiting |
| NCT07297875 |
A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in… |
Achondroplasia |
Not Yet Recruiting |
| Phase 1 |
| NCT06225804 |
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT05244551 |
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With… |
Solid Tumor |
Recruiting |
| NCT07288957 |
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors |
Solid Tumors (Phase 1) |
Recruiting |
| NCT04192344 |
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients… |
Neoplasms |
Recruiting |
| NCT04906434 |
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients… |
Advanced Liver Cancer |
Recruiting |
| NCT07700953 |
A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole… |
Healthy Participants |
Recruiting |
| NCT06896760 |
A Mass Balance Study of [14C]ABSK011 |
Healthy Subjects |
Not Yet Recruiting |
| NCT06884072 |
A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule… |
Healthy Subjects |
Active, Not Recruiting |
| NCT05627063 |
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients… |
Solid Tumor |
Active, Not Recruiting |
| NCT07718165 |
A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration |
Solid Tumor (Phase I) |
Not Yet Recruiting |
| Not specified |
| NCT07301463 |
A Study in Children With Achondroplasia |
Achondroplasia |
Recruiting |